AGT and essential hypertension: One study [62] found that PARP inhibitors may have an inhibitory effect on angiotensin II (Ang II) in rats, so we speculate that olaparib may reduces the risk of hypertension by inhibiting renin angiotensin system (RAS), an important factor in the occurrence and maintenance of essential hypertension [63].